Núria Rodríguez

Pompeu Fabra University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

M. Algara

Hospital Universitario 12 De Octubre

P. Foro

Hospital Del Mar

I. Membrive

Hospital Del Mar

E. Fernández-Velilla

Pompeu Fabra University

J. Lozano

Consorci Sanitari de Terrassa

X. Sanz

Hospital de Nens de Barcelona

J. Quera

Parc de Salut

A. Reig

Imperial College London

Felipe Couñago

Hospital Universitario Quirónsalud Madrid

O. Pera

Parc de Salut

Cooperative Institutions

Instituto de Salud Carlos III

147

Universitat Autònoma de Barcelona

147

Hospital Del Mar

112

Parc de Salut

108

Universitat de Barcelona

Centro de Investigación Biomédica en Red

Hospital Universitario La Paz

Universidad Autónoma de Madrid

Hospital del Mar Research Institute

Pompeu Fabra University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Re: Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases

JNCI Journal of the National Cancer Institute (2006)

P. Foro M. Algara Núria Rodríguez J. Sanz

10.1093/jnci/djj076

Cite

Citations (1)

Diagnosis and locoregional treatment of patients with breast cancer during the COVID-19 pandemic/ Diagnóstico y tratamiento locorregional de las pacientes con cáncer de mama durante la pandemia de la COVID-19

Ricardo Pardo Manel Algara M. Angeles Montero-Fernandez X. Sanz Mar Vernet

We are facing a pandemic that is going to affect a significant part of the population. At the end of April in the world there are about 3,000,000 cases, with 205,000 deaths and 860,000 patients recovered. The response to this pandemic has in many cases led to a significant change in the daily work of caring for cancer patients, the good results of which depend largely on time-adjusted protocols and multidisciplinary treatments. We present a review of local, surgical and radiotherapy treatment together with authors’ recommendations made from personal experience on ways to act in the diagnosis and surgical treatment of breast cancer during the COVID-19 pandemic. The multidisciplinary Breast Committees must continue to meet weekly in videoconference format. All surgical actions and irradiations must be carried out with maximum safety for both the patients and the participating teams. Hypofractionation in radiation therapy should be the standard treatment. Sometimes it is recommended to apply a primary systemic treatment or even a primary irradiation. Great coordination between the surgical and oncology teams, both medical and radiotherapeutic, is essential.

Pandemic

Radiation oncology

Source

Cite

Citations (0)

Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer (NSCLC)

Journal of Clinical and Translational Research (2021)

Sara Montemuiño Muñiz Soraya García-Sánchez Julia Calzas Rodríguez Beatriz Losada Vila E. Marcos Herrero

Background and Aim:In Stage IIIA-N2 non-small cell lung cancer (NSCLC), the accuracy of combined positron-emission tomography/computed tomography imaging (PET-CT), together with mediastinal staging techniques, has led to a wide range of challenging clinical scenarios in terms of therapeutic management.Concurrent chemoradiotherapy followed by consolidation immunotherapy remains the standard of care.In patients with potentially-resectable disease, surgery plays an important role in multimodal therapy.The introduction of targeted therapies and immune-checkpoint inhibitors has revolutionized multimodal treatment.In the present article, we review current treatment options and future trends in stage IIIA-N2 NSCLC.Relevance for Patients: This article provides insight into the current status of multimodal treatment for NSCLC to support decision-making in routine clinical practice.

Multimodal therapy

10.18053/jctres.07.202102.013

Cite

Citations (0)

EP01.51: Artificial intelligence in the optimisation of the quality of ultrasound images

Ultrasound in Obstetrics and Gynecology (2024)

Pablo Arbeláez A. Sarmiento Núria Rodríguez María Escobar Núria Rodríguez

10.1002/uog.28065

Cite

Citations (0)

Post‐irradiation Renbok phenomenon in erythema multiforme: Report of a case sparing previously irradiated areas

Journal of the European Academy of Dermatology and Venereology (2022)

Marta Bertolín‐Colilla Ferran Olmos‐Alpiste Núria Rodríguez Ramón M. Pujol

Erythema multiforme

Erythema

10.1111/jdv.18532

Cite

Citations (0)

Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children

BMC Urology (2018)

Adrián Rodríguez Concepción Sáez-Torres Concepcion Mir Paula Casasayas Núria Rodríguez

The diagnosis and follow-up of stone forming patients is usually performed by analysis of 24-h urine samples. However, crystallization risk varies throughout the day, being higher at night. The main objective of this study is to evaluate the urinary crystallization risk in adults and children by calculating risk indexes based on different collection periods.The study included 149 adults (82 healthy and 67 stone-formers) and 108 children (87 healthy and 21 stone-formers). 24-h urine was collected, divided into 12-h daytime sample (8 am to 8 pm), and 12-h overnight sample (8 pm to 8 am next morning). Solute concentrations, the calcium to citrate ratio (Ca/Cit), and the ion activity product of calcium oxalate (AP[CaOx]) and calcium phosphate (AP[CaP]) were calculated in each 12-h sample and in overall 24-h urine. Assessments were also related to stone type.Ca/Cit and AP(CaOx) were significantly higher in stone forming patients than in healthy subjects. The 12-h overnight samples had the highest values for both risk indexes, confirming a greater risk for crystallization at night. The AP(CaP) index was significantly higher in patients with pure hydroxyapatite stones than healthy controls, but was not significantly different between stone-formers overall and healthy controls.The calculation of risk indexes is a simple method that clinicians can use to estimate crystallization risk. For this purpose, the use of 12-h overnight urine may be a reliable alternative to 24-h collections.

Urinary stone

Urine sample

10.1186/s12894-018-0430-8

Cite

Citations (7)

Local relapse after radiotherapy in locally advanced breast cancer patients

Revista de Oncología (2001)

Miquel Sanz M. Algara Xavier Sanz Latiesas Núria Rodríguez Idoia Morilla Ruiz

10.1007/bf02719885

Cite

Citations (0)

[Quality of life and persistent symptoms after hospitalization for COVID-19. A prospective observational study comparing ICU with non-ICU Patients].

PubMed Central (2021)

Manuel Taboada Núria Rodríguez María Diaz-Vieito María Jesús Domínguez Ana Casal

Hospital admission

Source

Cite

Citations (1)

Evaluation of the Efficacy and Safety of Griflow® Dual, a Pre-Set Two-Flow Infusion Device for Intravenous Immunoglobulin (Flebogamma® 5%) Administration

The Journal of Vascular Access (2011)

Argentina Sánchez M. Sanjuan Alvarez María Adoración Bustillo María Carmen García M R Martín Muñoz

Purpose A single center, prospective study was performed to assess the efficacy and safety of Griflow® Dual–-a gravity-fed device for intravenous delivery of human immunoglobulin Flebogamma®. Methods A total of 2 infusions in 2 visits per patient were assessed using G2 and G3 Griflow® Dual models that provide different flow rates adjusted to the patient's weight. To follow the most common method of intravenous immunoglobulin administration, infusion through the two-way device commenced with the low flow rate capillary (clamp closed) for 30 minutes and continued with the high flow rate, opening both ways. Reliability of flow delivery (average flow rates), adverse events, as well as functionality in daily practice (questionnaire to nurses) were assessed. Results twenty-five valid infusions were evaluated on 13 subjects. Except for the G2 model with closed clamp in which 14.5% deviation was observed, actual average flow rate values fell well into the maximum 10% deviation permitted with respect to expected charted values (G2: 55 and 142 mL/h; G3: 76 and 189 mL/h). Discrepancies could be explained by patient's arm movements or posture change during infusion. No adverse events related to the study device occurred. In the functionality questionnaires, nurse's comfort and safety of infusion with Griflow® Dual were rated higher than without Griflow® Dual but lower than with infusion pumps. Conclusions Although it may not be as precise as an infusion pump, Griflow® Dual proved to be a reliable and suitable device to administer Flebogamma® 5%. Correct safety should be confirmed in a larger sample.

10.5301/jva.2011.8689

Cite

Citations (0)

ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells)

Clinical & Translational Oncology (2019)

I. Nieto Danielle M. Pastor Javier Rodríguez‐Cobos Jesús Pérez C. Méndez

Appendicular skeleton

Hyperthermic Intraperitoneal Chemotherapy

Primary tumor

10.1007/s12094-019-02091-1

Cite

Citations (2)